Policy objective of generic medicines from the investment perspective: The case of clopidogrel

Péter Elek, András Harsányi, Tamás Zelei, Kata Csetneki and Zoltán Kaló

Health Policy, 2017, vol. 121, issue 5, 558-565

Abstract: The objective of generic drug policies in most countries is defined from a disinvestment perspective: reduction in expenditures without compromising health outcomes. However, in countries with restricted access of patients to original patented drugs, the objective of generic drug policies can also be defined from an investment perspective: health gain by improved patient access without need for additional health budget.

Keywords: Clopidogrel; Generic drugs; Multilevel analysis; Patient access; Pharmaceutical policy (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851017300581
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:121:y:2017:i:5:p:558-565

DOI: 10.1016/j.healthpol.2017.02.015

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().